Chemfab Alkalis Recommends Final Dividend of ₹1.25/Share; Approves FY26 Results
Chemfab Alkalis announced its Q4 and FY26 results. The Board recommended a final dividend of ₹1.25 per share. M/s. Brahmayya & Co. was appointed as Internal Auditors and M/s. Madhavan, Mohan & Associates as Cost Auditors for FY27. The company confirmed it is not a 'Large Corporate'.
The dividend announcement and approval of financial results are material information for investors, impacting investment decisions.
The recommendation of a final dividend and the approval of financial results are positive developments for the company.
Chemfab Alkalis Limited announced the outcome of its Board Meeting held on May 13, 2026.
The Board approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The financial results, along with the Statutory Auditors' report declaring an unmodified opinion, were enclosed.
Furthermore, the Board recommended a Final Dividend of ₹1.25 per share for the shareholders' approval at the upcoming Annual General Meeting. The company also reappointed M/s. Madhavan, Mohan & Associates as Cost Auditors and M/s. Brahmayya & Co. as Internal Auditors for the financial year 2026-2027.
The Board meeting commenced at 2:00 P.M. and concluded at 7:00 P.M. Chemfab Alkalis Limited also confirmed its status as 'Not a Large Corporate' as per SEBI guidelines, with outstanding borrowings of ₹8143 Lakhs as of March 31, 2026.
What to do with a filing like this
Chemfab Alkalis Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chemfab Alkalis Limited. Read the original for the full detail.